| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aceragen, Inc. | CHIEF STRATEGY OFFICER | Common Stock | 452K | $230K | $0.51 | 17 Jan 2023 | Direct |
| Aceragen, Inc. | CHIEF STRATEGY OFFICER | Stock Options (Right to Buy) | 25.4K | 20 Jan 2023 | Direct | ||
| Aceragen, Inc. | CHIEF STRATEGY OFFICER | Series Z Convertible Preferred Stock | 0 | 17 Jan 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ACGN | Aceragen, Inc. | 20 Jan 2023 | 1 | $0 | 4 | CHIEF STRATEGY OFFICER | 02 Feb 2023, 19:13 |
| ACGN | Aceragen, Inc. | 17 Jan 2023 | 2 | $0 | 4 | Chief Strategy Officer | 19 Jan 2023, 20:47 |
| IDRA | IDERA PHARMACEUTICALS, INC. | 06 Jan 2023 | 2 | -$52.5K | 4 | CHIEF STRATEGY OFFICER | 10 Jan 2023, 20:19 |
| IDRA | IDERA PHARMACEUTICALS, INC. | 28 Sep 2022 | 2 | $0 | 4 | Chief Strategy Officer | 30 Sep 2022, 21:48 |
| IDRA | IDERA PHARMACEUTICALS, INC. | 28 Sep 2022 | 0 | $0 | 3 | Chief Strategy Officer | 30 Sep 2022, 21:44 |